Work

Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab

Year: 2020

Type: article

Abstract: Cutaneous T-cell lymphoma (CTCL) is a common cutaneous malignancy. Although early-stage disease is treatable with local therapies, including topical corticosteroids, retinoids, and alkylating agents, more advanced disease poses a therapeutic challenge. CTCL is highly radiation sensitive, but recurrence is common. Advanced disease is often lethal, with death caused by progression or bacterial sepsis from cutaneous infection.1 Many systemic treatments have been attempted for advanced disease, but complete remission is uncommon.

Source: JAAD Case Reports

DOI: 10.1016/j.jdcr.2020.05.035

Authors: Sarah A. Westergaard, Mary Jo Lechowicz, Maggie Harrington, Justin Elsey, Jack L. Arbiser, Mohammad K. Khan

Institution: Emory University

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $600